6-K ·Filed Jul 30, 2026

GSK

GSK plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001654954-26-007005
Actionable Insight • Neutral

No actionable trading signal. This is a routine PDMR share sale disclosure with no bearing on GSK's fundamentals. Monitor for any cluster of insider sales or changes in executive shareholding patterns in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
GSK ▼ -3.46% at T+20d
NEUTRAL call ✗ call lost -3.46% · α vs SPY -7.42% · entry $52.07 → $50.27
Next anchor: T+60d in 21d
Latest observation: T+43 -0.95% FF3 residual α
Entry anchored
Jul 30, 12:25 PM ET
via exchange tick
T+1d
-0.73%
call -0.73% · α -1.44%
$51.69
settled 2mo ago
T+5d
+0.19%
call +0.19% · α -3.43%
$52.17
settled 8w ago
T+20d
-3.46%
call -3.46% · α -7.42%
$50.27
settled 5w ago
T+60d
—
call — · α —
—
in 21d

Price Chart

Loading chart...

Executive Summary

GSK filed a routine 6-K disclosing that President of Global Supply Chain Regis Simard sold 38,000 ordinary shares at £20.38 on July 29, 2026. The sale is a single PDMR transaction with no material financial impact on the company. This filing is administrative in nature and does not signal any change in GSK's business operations or financial health.

Key Facts

  • President of Global Supply Chain Regis Simard sold 38,000 ordinary shares on July 29, 2026
  • Sale price was £20.38 per share
  • Transaction executed on the London Stock Exchange (XLON)
  • Filing is a standard PDMR transaction notification under UK rules

Financial Impact

Sale of 38,000 shares at £20.38 totals approximately £774,440 — immaterial relative to GSK's $107.8B market cap

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
43% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (GSK) — Batch item 10001654954-26-007005
Document: 0001654954-26-007005-index-headers.html0001654954-26-007005
Document: 0001654954-26-007005-index.html0001654954-26-007005
Document: 0001654954-26-007005.txt0001654954-26-007005
6-K Filing (GSK) — Batch item 50001654954-26-007005
Document: 0001654954-26-007005-index-headers.html0001654954-26-007005
Document: 0001654954-26-007005-index.html0001654954-26-007005
Document: 0001654954-26-007005.txt0001654954-26-007005
42 reports for GSK
Performance horizon
69% Hit rate 11 of 16 directional calls best @ T+60▲ +7.85%Jun 16, 2026
Filters
Rows
Reports for GSK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 5/10
$50.01 $50.22▲ +0.42%▼ −0.40%$47.03 (−5.96%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 1/10
$48.13 $50.22▲ +4.34%▲ +4.56%$47.03 (−2.29%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 1/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 3/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 6/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 1/10
$51.43 $50.44▼ −1.92%▼ −1.80%$47.03 (−8.56%)
Aug 24, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$51.78 $50.25▼ −2.95%▼ −3.42%$47.03 (−9.17%)
Showing 10 of 42

US Market Status

Market Closed — Opens Mon (64h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access